Julian Muller
Overview
Explore the profile of Julian Muller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lichtblau M, Schwarz E, Ulrich T, Schneider S, Bauer M, Furian M, et al.
Ann Am Thorac Soc
. 2025 Mar;
PMID: 40085143
Background: Patients with pulmonary vascular disease (PVD) often reveal nocturnal hypoxemia and sleep apnea. We investigated whether exposure to high altitude worsens those conditions. Methods: In a randomized-controlled crossover trial,...
2.
Wick C, Constam E, Schneider S, Titz A, Furian M, Lichtblau M, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004681
: Pulmonary rehabilitation clinics are traditionally located at higher altitudes (HAs), where lower PO reduces exercise capacity and blood oxygenation. Eccentric cycling exercise (ECC), with its lower cardiorespiratory demand compared...
3.
Lichtblau M, Schneider S, Muller J, Bauer M, Carta A, Carta A, et al.
Am J Respir Crit Care Med
. 2025 Jan;
PMID: 39847730
No abstract available.
4.
Hofer S, Frasch L, Brajkovic S, Putzker K, Lewis J, Schurmann H, et al.
Mol Syst Biol
. 2025 Jan;
21(3):231-253.
PMID: 39838187
The DNA-damaging agent Gemcitabine (GEM) is a first-line treatment for pancreatic cancer, but chemoresistance is frequently observed. Several clinical trials investigate the efficacy of GEM in combination with targeted drugs,...
5.
Maciel E, Eisert J, Muller J, Habeck T, Lermyte F
J Am Soc Mass Spectrom
. 2025 Jan;
36(2):355-367.
PMID: 39812073
Molecular glues (MGs) and proteolysis-targeting chimeras (PROTACs) are used to modulate protein-protein interactions (PPIs), via induced proximity between compounds that have little or no affinity for each other naturally. They...
6.
Muller J, Bayer F, Wilhelm M, Schuh M, Kuster B, The M
Nat Commun
. 2025 Jan;
16(1):510.
PMID: 39779715
Post-translational modifications (PTMs) play pivotal roles in regulating cellular signaling, fine-tuning protein function, and orchestrating complex biological processes. Despite their importance, the lack of comprehensive tools for studying PTMs from...
7.
Preiss H, Mayer L, Furian M, Schneider S, Muller J, Saxer S, et al.
Open Heart
. 2025 Jan;
12(1.
PMID: 39756820
Background: Hypoxic pulmonary vasoconstriction leads to an increase in pulmonary artery pressure (PAP) and potentially right heart failure in healthy individuals and patients with respiratory diseases. Previous studies in patients...
8.
Muller J, Lichtblau M, Saxer S, Schmucki M, Furian M, Schneider S, et al.
Eur Heart J Open
. 2024 Dec;
4(6):oeae097.
PMID: 39698150
Aims: More than 220 Mio people live at altitudes above 2000 m, many of whom have pre-existing chronic diseases, including pulmonary vascular diseases (PVDs) such as pulmonary arterial hypertension (PAH)...
9.
Schwarz E, Saxer S, Lichtblau M, Schneider S, Muller J, Mayer L, et al.
ERJ Open Res
. 2024 Oct;
10(5).
PMID: 39469274
Background: Patients with pulmonary vascular disease (PVD) often suffer from nocturnal hypoxaemia, but also from sleep apnoea. Short-term use of acetazolamide increases ventilation due to metabolic acidosis and also reduces...
10.
Herzig J, Ulrich S, Schneider S, Muller J, Lichtblau M, Ulrich T, et al.
ERJ Open Res
. 2024 Oct;
10(5).
PMID: 39469267
Background: Hypoxia is a trigger for sympathetic activation and autonomic cardiovascular dysfunction. Pulmonary vascular disease (PVD) is associated with hypoxaemia, which increases with altitude. The aim was to investigate how...